CDMRP Neurofibromatosis Research Program: Neurofibromatosis Research Academy - Scholar Award

This award mechanism enables the Scholar to pursue a neurofibromatosis project that may be basic, translational, and/or clinical research, and addresses at least one of the FY23 NFRP Areas of Emphasis under the guidance of a Career Guide. The PI must be an early-career researcher or physician-scientist within 7 years of completion of their terminal degree by the time of the application deadline. 

Areas of Emphasis:

• NF2 and Schwannomatosis-related areas (e.g., hearing, balance, schwannoma, ependymoma, meningioma, LZTR1, SMARCB1)
• Endpoint validation, biomarker discovery, and technological innovation for assessments
• Application of data science
• Non-tumor manifestations
• Heterogeneity of NF-related phenotypes
• Genetics, genomics, epigenetics, systems biology, metabolomics, or similar approaches
• Preclinical efficacy studies
• Target identification and drug discovery • Nutritional, environmental, and other modifiers of NF
• Health services research

It is expected that three (3) awards will be granted. 

Funding: $750,000 total
Duration: 3 years

Research Authority due date: 3.8.23 10.9.23

Pre application (required)  due date: 11.8.23 21.9.23
Full proposal due date: 25.8.23 5.10.23